Evaluating feasibility and preliminary effects of a patient portal on empowerment of breast and lung cancer patients and survivors

• Conditions: breast cancer and lung cancer; 10006291

• Registration Number: NL-OMON38681
• Lead Sponsor: Antoni van Leeuwenhoek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 320

Inclusion Criteria

Patients with a histologically confirmed breast cancer or non-small cell lung cancer who will be treated with curative-intent (including lung cancer patients receiving concurrent chemo- and radiation therapy).

Exclusion Criteria

-Significant cognitive impairment (such as post stroke, dementia etc.)
-Presence of metastases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To study feasibility and acceptability as well as the effects of the patient<br /><br>portal on patient empowerment, physical activity, communication, dyspnea (lung<br /><br>cancer) and quality of life</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>